hexamethonium has been researched along with Blindness in 2 studies
Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.
Blindness: The inability to see or the loss or absence of perception of visual stimuli. This condition may be the result of EYE DISEASES; OPTIC NERVE DISEASES; OPTIC CHIASM diseases; or BRAIN DISEASES affecting the VISUAL PATHWAYS or OCCIPITAL LOBE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| GOLDSMITH, AJ | 1 |
| HEWER, AJ | 1 |
| BRUCE, GM | 1 |
2 other studies available for hexamethonium and Blindness
| Article | Year |
|---|---|
Unilateral amaurosis with partial recovery after using hexamethonium iodide.
Topics: Amblyopia; Blindness; Cardiovascular Agents; Hexamethonium; Muscle Relaxants, Central; Physiological | 1952 |
Permanent bilateral blindness following the use of hexamethonium chloride.
Topics: Blindness; Hexamethonium; Hypertension; Muscle Relaxants, Central; Vision Disorders | 1955 |